Lesson plan
Cefcapene
Cefcapene (INN) is a third-generation cephalosporin antibiotic. It was patented in 1985 and approved for medical use in 1997 in Japan, where it is sold under the Tradename Flomox by Shionogi & Co., Ltd. It is also approved and available as a generic in South Korea and China. It is known to cause severe hypocarnitinemia and associated serious hypoglycaemia, seizures, and encephalopathy in children.
Article summary
Cefcapene (INN) is a third-generation cephalosporin antibiotic. It was patented in 1985 and approved for medical use in 1997 in Japan, where it is sold under the Tradename Flomox by Shionogi & Co., Ltd. It is also approved and available as a generic in South Korea and China. It is known to cause severe hypocarnitinemia and associated serious hypoglycaemia, seizures, and encephalopathy in children.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.